CLINICAL_TRIALS
research
· 2025-03-06
Clinical Trial Update: Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases [Phase 2]
Summary
A Phase 2 clinical trial at Zhejiang Cancer Hospital evaluates cerebrospinal fluid cytology-guided intrathecal chemotherapy with chemo-holiday therapy for EGFR-…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Zhejiang Cancer Hospital | Conditions: Leptomeningeal Metastases | Phase 2 | Status: NOT_YET_RECRUITING